Peli BioThermal Acquires Evo (SAVSU) from BioLife Solutions

October 7, 2025

Peli BioThermal, a Platinum Equity‑backed temperature‑controlled logistics provider, acquired the Evo portfolio (SAVSU Cleo Technologies, LLC) from BioLife Solutions for $25.5 million in cash (subject to adjustments). The add‑on expands Peli BioThermal’s cryogenic and cold‑chain offerings—including the evoIS platform—and preserves the Bruce Township, Michigan operations to support Cell & Gene Therapy and pharmaceutical customers.

Buyers
Peli BioThermal, Platinum Equity
Targets
Evo (SAVSU Cleo Technologies, LLC)
Sellers
BioLife Solutions, Inc.
Platforms
Peli BioThermal
Location
Michigan, United States
Transaction Type
Addon

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.